Gisela Marie Sitbon

Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden.

Visionar Preclinical AB is a CRO specialized on in vivo preclinical contract research and services. The company was founded year 2000 by individuals with extensive experience of preclinical research and development in international pharmaceutical companies. Its customers are small and mid-size companies who work with drugs, biopharmaceuticals, or medical devices. Quality and flexibility are key factors in their work. Its extensive experience makes it possible for them to find unconventional solutions to preclinical matters. It work closely with their Sponsors to develop strategies for cost effective evaluation of drug candidates and to perform necessary regulatory studies for phase I-II clinical trials.

Part of Chalmers University of Technology Foundation, Encubator AB is an alternative investment manager. The private company is based in Gothenburg, Sweden. The Swedish company was founded in 2004. The CEO is Jonas Berggren.

ENCare AB provides interactive and web-based information system for healthcare industry. It offers an interface for the collection, documentation, and feedback of performance from clinical experts. The company was founded by Olle Harald Ljungqvist and Knut Ivar Magnus Stafsing in 2009 and is headquartered in Stockholm, Sweden.

Arterion AB is a holding company that manufactures biomaterials, including artificial blood vessels, consisting of microbial derived cellulose for revascularization of patients with cardiovascular diseases. It focuses on pure uncoated cellulose grafts as replacement of human vessels, primarily as bypass grafts. Its manufacturing method is based on a novel technology that controls the life conditions of the microbe Gluconacetobacter xylinus. Its use of microbial derived cellulose will allow clinicians to use artificial blood vessels as replacement for vessels with an internal diameter of less than five millimeters. The company was founded on January 4, 2007 and is headquartered in Gothenburg, Sweden.

Gradientech AB operates as biotech and diagnostics company. It develops and provides ultra-rapid antibiotic susceptibility testing products. The company's products include QuickMic, CellDirector and Tracking Tool PRO. Gradientech was founded by Sara Ulrika Thorslund and Johan Kreuger in 2009 and is headquartered in Uppsala, Sweden.

CollaboDoc AB designs and develops digital process tools for healthcare industry. Its process tools software supports to develop acute care concept where patients with acute problems can be attended. The company was founded by Lars Staffan Bjessmo on December 3, 2012 and is headquartered in Stockholm, AB.

Aifloo AB was developed self-learning e-health system software for senior facilities and nursing homes. The company was founded by Michael Collaros, Anders Nils Gunnar Widgren and Felix Karl Josef Etzler in 2015 and was headquartered in Stockholm, Sweden.

EnginZyme AB is a Swedish company founded in 2014 by Samuel Härgestam, Robin Chatterjee, and Karim Engelmark Cassimjee. EnginZyme is based in Stockholm, Sweden, and has a multidisciplinary team of experts in biocatalysis, organic chemistry, enzyme and process engineering, as well as AI and machine learning. The company has developed a patented, cell-free biomanufacturing platform that combines the power of biology with the efficiencies of the chemical industry. EnginZyme aims to produce better, greener, and more affordable products sustainably. The company's enzyme immobilisation technology enables biomanufacturing without living organisms, resulting in lower costs and a smaller environmental footprint. The company has been recognized as a technology pioneer by the World Economic Forum and was selected for the Cleantech 100 list in 2022 and 2023. Karim Engelmark Cassimjee has been the CEO since 2014.

In Singulo Solutions AB provides biotechnology research and development services. The company is based in Mölndal, Sweden.